GPT and metabolic dysfunction-associated steatotic liver disease: After HSYA intervention, there was no significant change in TG levels, but high-dose HSYA significantly reduced TC levels, and ALT and AST levels showed significant improvement (P < 0.05), suggesting that high-dose HSYA effectively alleviated liver damage and oxidative stress in NAFLD mice (Figure 3).